Published by
@ShahidNShah
@ShahidNShah
AstraZeneca Working With Mass General on Tech for Heart Failure, Asthma
The biotechnology company AstraZeneca announced on Tuesday that it would be collaborating with Massachusetts General Hospital to create and clinically validate patient-centric digital health solutions.
According to the company, the collaboration will use AstraZeneca's new AMAZE disease management platform to study heart failure and asthma management.
"We are incredibly proud to be working closely with Massachusetts General Hospital to utilize this digital platform to close gaps in patient care, ultimately leading to better outcomes," said Ruud Dobber, president of the BioPharmaceuticals Business Unit at AstraZeneca.
"Digital medicine helps individuals manage their chronic conditions from home while staying connected to a dedicated care team that monitors their digital device readings while driving personalized results through lifestyle coaching and medication management," said Dr. David Houghton, medical director for telemedicine and digital medicine at Ochsner.
Continue reading at healthcareitnews.com
Make faster decisions with community advice
- 6 Benefits of Adopting Agile Principles in Healthcare
- How Collaboration Accelerates Innovation During the Pandemic
- How to Use Automation in Healthcare Marketing
- Humana Teams With Mercy to Expand Access to Virtual Care
- Philips and Rennes University Hospital Sign Five-Year Technology, Research and Innovation Partnership to Advance Patient Care
Next Article
-
Most Consumers Want to Keep Telehealth After the COVID-19 Pandemic
Before the COVID-19 pandemic, telehealth was more of a novelty than a necessity. The concept of touching base with a doctor remotely was promising, but there were hurdles. Numbers recorded over that …
